Search
Study Opens Up Possibility for Use of Precision Medicine in Pediatric Cancer
- OPACC
- Jun 1, 2020
- 1 min read
Matching children diagnosed with advanced cancers to targeted anti-cancer agents appears to show some potential for improving progression-free survival.
Recent Posts
See AllThe FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type...
Untreated growth hormone deficiency was associated with neurocognitive impairment and reduced physical functioning among adult survivors...
A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic...